438 related articles for article (PubMed ID: 24035975)
1. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
2. Nanobody-based cancer therapy of solid tumors.
Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
[TBL] [Abstract][Full Text] [Related]
3. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
Hu Y; Liu C; Muyldermans S
Front Immunol; 2017; 8():1442. PubMed ID: 29163515
[TBL] [Abstract][Full Text] [Related]
5. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
7. Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.
Altintas I; Kok RJ; Schiffelers RM
Eur J Pharm Sci; 2012 Mar; 45(4):399-407. PubMed ID: 22064454
[TBL] [Abstract][Full Text] [Related]
8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
9. [Molecular target therapy: a milestone on the road for curing cancer].
Zeng YX; Zhang XS; Liu Q
Ai Zheng; 2008 Aug; 27(8):785-7. PubMed ID: 18710609
[TBL] [Abstract][Full Text] [Related]
10. [Molecular imaging in cancer therapy].
Weber WA
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
[TBL] [Abstract][Full Text] [Related]
12. Antibodies and peptides in cancer therapy.
Khandare JJ; Minko T
Crit Rev Ther Drug Carrier Syst; 2006; 23(5):401-35. PubMed ID: 17425513
[TBL] [Abstract][Full Text] [Related]
13. Nanobody; an old concept and new vehicle for immunotargeting.
Rahbarizadeh F; Ahmadvand D; Sharifzadeh Z
Immunol Invest; 2011; 40(3):299-338. PubMed ID: 21244216
[TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.
Roovers RC; Laeremans T; Huang L; De Taeye S; Verkleij AJ; Revets H; de Haard HJ; van Bergen en Henegouwen PM
Cancer Immunol Immunother; 2007 Mar; 56(3):303-317. PubMed ID: 16738850
[TBL] [Abstract][Full Text] [Related]
15. Antibody-targeted nanoparticles for cancer therapy.
Fay F; Scott CJ
Immunotherapy; 2011 Mar; 3(3):381-94. PubMed ID: 21395380
[TBL] [Abstract][Full Text] [Related]
16. Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: New biology and novel targeting systems.
Nikkhoi SK; Rahbarizadeh F; Ahmadvand D
Protein Expr Purif; 2017 Jan; 129():115-121. PubMed ID: 27693491
[TBL] [Abstract][Full Text] [Related]
17. Mapping cytoskeletal protein function in cells by means of nanobodies.
Van Audenhove I; Van Impe K; Ruano-Gallego D; De Clercq S; De Muynck K; Vanloo B; Verstraete H; Fernández LÁ; Gettemans J
Cytoskeleton (Hoboken); 2013 Oct; 70(10):604-22. PubMed ID: 23818458
[TBL] [Abstract][Full Text] [Related]
18. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
Liu M; Li L; Jin D; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies as novel agents for cancer therapy.
Revets H; De Baetselier P; Muyldermans S
Expert Opin Biol Ther; 2005 Jan; 5(1):111-24. PubMed ID: 15709914
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
